Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease
- PMID: 10398297
- DOI: 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P
Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease
Abstract
Parkinson's disease (PD) is an age-related disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra (SN) and corresponding motor deficits. Oxidative stress and mitochondrial dysfunction are implicated in the neurodegenerative process in PD. Although dietary restriction (DR) extends lifespan and reduces levels of cellular oxidative stress in several different organ systems, the impact of DR on age-related neurodegenerative disorders is unknown. We report that DR in adult mice results in resistance of dopaminergic neurons in the SN to the toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MPTP-induced loss of dopaminergic neurons and deficits in motor function were ameliorated in DR rats. To mimic the beneficial effect of DR on dopaminergic neurons, we administered 2-deoxy-D-glucose (2-DG; a nonmetabolizable analogue of glucose) to mice fed ad libitum. Mice receiving 2-DG exhibited reduced damage to dopaminergic neurons in the SN and improved behavioral outcome following MPTP treatment. The 2-DG treatment suppressed oxidative stress, preserved mitochondrial function, and attenuated cell death in cultured dopaminergic cells exposed to the complex I inhibitor rotenone or Fe2+. 2-DG and DR induced expression of the stress proteins heat-shock protein 70 and glucose-regulated protein 78 in dopaminergic cells, suggesting involvement of these cytoprotective proteins in the neuroprotective actions of 2-DG and DR. The striking beneficial effects of DR and 2-DG in models of PD, when considered in light of recent epidemiological data, suggest that DR may prove beneficial in reducing the incidence of PD in humans.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
-
Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism.J Neurosci Res. 1999 Sep 15;57(6):830-9. J Neurosci Res. 1999. PMID: 10467254
-
CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.J Pharmacol Exp Ther. 1999 Feb;288(2):421-7. J Pharmacol Exp Ther. 1999. PMID: 9918541
-
The mouse MPTP model: gene expression changes in dopaminergic neurons.Eur J Neurosci. 2003 Jan;17(1):1-12. doi: 10.1046/j.1460-9568.2003.02408.x. Eur J Neurosci. 2003. PMID: 12534964
-
Mechanisms of MPTP toxicity.Mov Disord. 1998;13 Suppl 1:35-8. Mov Disord. 1998. PMID: 9613716 Review.
-
Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).J Neural Transm Suppl. 2006;(70):273-6. J Neural Transm Suppl. 2006. PMID: 17017541 Review.
Cited by
-
Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein.Neurobiol Aging. 2013 Mar;34(3):928-35. doi: 10.1016/j.neurobiolaging.2012.07.008. Epub 2012 Aug 9. Neurobiol Aging. 2013. PMID: 22883907 Free PMC article.
-
Role of Sirtuins in Linking Metabolic Syndrome with Depression.Front Cell Neurosci. 2016 Mar 31;10:86. doi: 10.3389/fncel.2016.00086. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27065808 Free PMC article. Review.
-
Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake.Proc Natl Acad Sci U S A. 2003 May 13;100(10):6216-20. doi: 10.1073/pnas.1035720100. Epub 2003 Apr 30. Proc Natl Acad Sci U S A. 2003. PMID: 12724520 Free PMC article.
-
Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease.J Mol Neurosci. 1999 Aug-Oct;13(1-2):159-65. doi: 10.1385/JMN:13:1-2:159. J Mol Neurosci. 1999. PMID: 10691302
-
Infectious agents and age-related neurodegenerative disorders.Ageing Res Rev. 2004 Jan;3(1):105-20. doi: 10.1016/j.arr.2003.08.005. Ageing Res Rev. 2004. PMID: 15163105 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
